Rx PharmFilm® Approvals
Rx Market Opportunity
Development Pipeline
Partnered Products




Rx PharmFilm® Approvals

Two prescription products, utilizing MonoSol Rx’s PharmFilm® Technology, have received FDA approval in 2010. MonoSol Rx developed both formulations and the products are commercially manufactured in our state-of-the-art production facility located in Portage, Indiana. These Rx products will be marketed by our commercial partners.


  • Drug
  • Indication
  • Approval Date
  • Marketing Partner
  • Zuplenz
    (Ondansetron)
  • Treatment of Nausea
    & Vomiting
  • July, 2010
  • Strativa Pharmaceuticals
  • Suboxone (Buprenorphine/
    Naloxone)
  • Treatment of Opioid Dependence
  • August, 2010
  • Reckitt Benckiser

© 2007 Legal notices